Jump to contents

Researcher Information

last modified:2019/08/12

Professor YONEDA Takashi

Mail Laboratory Website

Faculty, Affiliation

Institute of Liberal Arts and Science

College and School Educational Field

Division of Medical Sciences, Graduate School of Medical Science
Division of Medical Science, Graduate School of Medical Science

School of Medicine, College of Medical, Pharmaceutical and Health Sciences
Department of Laboratory Sciences,School of Health Sciences, College of Medical, Pharmaceutical and Health Sciences

Laboratory

Department of Health Promotion and Medicine of the Future, Kanazawa University TEL:076-265-2252 FAX:076-234-4251

Academic Background

【Academic background(Doctoral/Master's Degree)】
Kanazawa University Doctor 1994 Completed
【Academic background(Bachelor's Degree)】
Kanazawa University 199003

Career

Kanazawa University(1999/04/01-)

Year & Month of Birth

Academic Society








The Endocrine Society
Japan Diabetes Society




Award

Specialities

Endocrinology、Hypertension、Endocrinology、Metabolomics、Cardiovascular medicine、Medical sociology

Speciality Keywords

Endocrinology, Hypertension, Medical Innovation, Reguratory Science, Telemedicine,Health Promotion

Research Themes

Study on Pathogenesis of Endocrine tumor

Hypertension, Cardiovascular Endocrinology

Medical Innovation

Books

Papers

  •  Effect of sodium glucose cotransporter 2 inhibitors on obstructive sleep apnea in patients with type 2 diabetes. Sawada K, Karashima S, Kometani M, Oka R, Takeda Y, Sawamura T, Fujimoto A, Demura M, Wakayama A, Usukura M, Yagi K, Takeda Y, Yoneda T. Endocr J.  2018/04
  •  The status of glycemic control and hypoglycemia in elderly patients visiting the outpatient department specializing in diabetes.  Soma Y, Oka R, Fujii S, Ito N, Kometani M, Karashima S, Takeda Y, Yoneda T, Asano A. Nihon Ronen Igakkai Zasshi.  2018/05
  •  Insulin Secretion and Risk for Future Diabetes in Subjects with a Nonpositive Insulinogenic Index.  Aono D, Oka R, Kometani M, Takeda Y, Karashima S, Yoshimura K, Takeda Y, Yoneda T. J Diabetes Res. 2018/03
  •  Impact of aldosterone-producing cell clusters on diagnostic discrepancies in primary aldosteronism. Kometani M, Yoneda T, Aono D, Karashima S, Demura M, Nishimoto K, Yamagishi M, Takeda Y. Oncotarget. 2018/05
  •  Correlation Between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism.  Umakoshi H, Tsuiki M, Yokomoto-Umakoshi M, Takeda Y, Takashi Y, Kurihara I, Itoh H, Katabami T, Ichijo T, Wada N, Shibayama Y, Yoshimoto T, Ashida K, Ogawa Y, Kawashima J, Sone M, Inagaki N, Takahashi K, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yanase T, Hashimoto S, Yamada M, Yoshikawa Y, Kai T, Suzuki T, Kawamura T, Naruse M. J Endocr Soc. 2018/05

show all

  •  Severe Mitral Regurgitation As a Result of Rupture of Mitral Valve Chordae Tendineae in a Patient With Graves Disease.  Karashima S, Tsuda T, Kometani M, Oka R, Demura M, Kawashiri MA, Takeda Y, Hayashi K, Yoneda T. J Endocr Soc. 2018/09
  •  Associations between Sleep-Disordered Breathing and Metabolic Risk Factors beyond Obesity. Wakabayashi Y, Oka R, Nakaya M, Karashima S, Kometani M, Sakurai M, Yoshimura K, Yoneda T. J Diabetes Res. 2018/10
  •  Madelung disease in a 58-year-old man.  Karashima S, Yoneda T. CMAJ.  2019/01
  •  C-Peptide Area Under the Curve at Glucagon Stimulation Test Predicts Glucose Improvements by GLP-1 Receptor Analogue: A Retrospective Observational Study.  Ohbatake A, Yagi K, Karashima S, Shima Y, Miyamoto Y, Asaka H, Okazaki S, Kometani M, Kawashiri MA, Takeda Y, Yoneda T, Chujo D. Diabetes Ther.  2019/02
  •  Study Protocol for the Effects of Artificial Intelligence (AI)-Supported Automated Nutritional Intervention on Glycemic Control in Patients with Type 2 Diabetes Mellitus. Oka R, Nomura A, Yasugi A, Kometani M, Gondoh Y, Yoshimura K, Yoneda T. Diabetes Ther.  2019/03
  •  The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism.  Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T, Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K, Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T. J Endocr Soc 2018/05
  •  Epigenetic Regulation of Aldosterone Synthase Gene by Sodium and Angiotensin II.  Takeda Y, Demura M, Wang F, Karashima S, Yoneda T, Kometani M, Hashimoto A, Aono D, Horike SI, Meguro-Horike M, Yamagishi M, Takeda Y. J Am Heart Assoc. 2018/05
  •  Insulin Secretion and Risk for Future Diabetes in Subjects with a Nonpositive Insulinogenic Index. Aono D, Oka R, Kometani M, Takeda Y, Karashima S, Yoshimura K, Takeda Y, Yoneda T. J Diabetes Res. 2018/05
  •  The Occurrence of Apparent Bilateral Aldosterone Suppression in Adrenal Vein Sampling for Primary Aldosteronism. Shibayama Y, Wada N, Naruse M, Kurihara I, Ito H, Yoneda T, Takeda Y, Umakoshi H, Tsuiki M, Ichijo T, Fukuda H, Katabami T, Yoshimoto T, Ogawa Y, Kawashima J, Ohno Y, Sone M, Fujita M, Takahashi K, Shibata H, Kamemura K, Fujii Y, Yamamoto K, Suzuki T.  J Endocr Soc.  2 5 398-407 2018/03
  •  Prevalence of primary aldosteronism without hypertension in the general population: Results in Shika study. Karashima S, Kometani M, Tsujiguchi H, Asakura H, Nakano S, Usukura M, Mori S, Ohe M, Sawamura T, Okuda R, Hara A, Takamura T, Yamagishi M, Nakamura H, Takeda Y, Yoneda T. Clin Exp Hypertens. 40 2 118-125 2018/03
  •  Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan. Ohno Y, Sone M, Inagaki N, Yamasaki T, Ogawa O, Takeda Y, Kurihara I, Itoh H, Umakoshi H, Tsuiki M, Ichijo T, Katabami T, Tanaka Y, Wada N, Shibayama Y, Yoshimoto T, Ogawa Y, Kawashima J, Takahashi K, Fujita M, Watanabe M, Matsuda Y, Kobayashi H, Shibata H, Kamemura K, Otsuki M, Fujii Y, Yamamoto K, Ogo A, Okamura S, Miyauchi S, Fukuoka T, Izawa S, Yoneda T, Hashimoto S, Yanase T, Suzuki T, Kawamura T, Tabara Y, Matsuda F, Naruse M; Nagahama Study; JPAS Study Group. Hypertension 71 3 530-537 2018/03
  •  Reply to Kawada: One-hour plasma glucose as a predictor of Type 2 diabetes mellitus.  Oka R, Aizawa T, Yoneda T, Yamagishi M. Diabet Med. 34 5 734. 2017
  •  Renal glucosuria is not associated with atherosclerotic cardiovascular disease outcome in a general Japanese community.  Tada H, Kawashiri MA, Sakata K, Yoneda T, Yasuda K, Yamagishi M, Hayashi K. Atherosclerosis. 261 111-116. 2017/06
  •  Cortisol overproduction results from DNA methylation of CYP11B1 in hypercortisolemia. Kometani M, Yoneda T, Demura M, Koide H, Nishimoto K, Mukai K, Gomez-Sanchez CE, Akagi T, Yokota T, Horike SI, Karashima S, Miyamori I, Yamagishi M, Takeda Y. Sci Rep.  7 1 11205 2017/09/11
  •  Trajectories of Postload Plasma Glucose in the Development of Type 2 Diabetes in Japanese Adults. Oka R, Shibata K, Sakurai M, Kometani M, Yamagishi M, Yoshimura K, Yoneda T. J Diabetes Res. 5307523.  2017
  •  Ventricular Fibrillation Associated With Dynamic Changes in J-Point Elevation in a Patient With Silent Thyroiditis.  Karashima S, Tsuda T, Wakabayashi Y, Kometani M, Demura M, Ichise T, Kawashiri MA, Takeda Y, Hayashi K, Yoneda T. J Endocr Soc.  2 2 135-139. 2017/12/06
  •  Protective effects of mineralocorticoid receptor blockade against neuropathy in experimental diabetic rats.  DIABETES OBESITY & METABOLISM 14 2 155-162 2012/02
  •  Unilateral Primary Aldosteronism with Spontaneous Remission after Long-Term Spironolactone Therapy.  JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 2012/02
  •  Multiple noncoding exons 1 of nuclear receptors NR4A family (nerve growth factor-induced clone B, Nur-related factor 1 and neuron-derived orphan receptor 1) and NR5A1 (steroidogenic factor 1) in human cardiovascular and adrenal tissues.  J Hypertens. 29 6 1185-95 2011/06
  •  Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects.  HYPERTENSION RESEARCH 34 1 98-102 2011/01
  •  Clinical characteristics of primary hyperaldosteronism due to adrenal microadenoma.  STEROIDS 76 12 1363-6 2011/11
  •  Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats. J Hypertens. 19 7 635-639 2001/03
  •  Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus. HUMAN MUTATION 19 1 23-29 2002/01
  •  Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. Circulation. 105 6 677-679 2002/02
  •  Genetic analysis of the cytochrome P-450c17alpha (CYP17) and aldosterone synthase (CYP11B2) in Japanese patients with 17alpha-hydroxylase deficiency. Clin Endocrinol 54 6 751-758 2001/06
  •  Cardiac aldosterone production in genetically hypertensive rats. Hypertension. 36 10 495-500 2000/10
  •  Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. Endocrinology. 141 5 1901-1904 2000/05
  •  Brain nitric oxide synthase messenger RNA in central mineralocorticoid hypertension. Hypertension. 30 4 953-956 1997/10

Conference Presentations

Arts and Fieldwork

Patent

Theme to the desired joint research

○The role of cardiovacular hormone in the pathogenesis of hypertension

Grant-in-Aid for Scientific Research

○「末端肥大症の成因における遺伝子学的研究」(2001-) 
○「生活習慣病における多機能携帯電話を用いた遠隔診療システムの構築」(2017-2019) 
○「地域医療における軽症糖尿病患者に対する在宅健康サービスの継続研究」(2013-2015)
○「地域医療における軽症糖尿病患者に対する在宅健康サービスの構築」(2010-2012) 

Classes (Bachelors)

Classes (Graduate Schools)

○Seminar of Medical Innovation(2017)
○Seminar of Medical Innovation(2017)
○Seminar on Regulatory Science(2017)
○Seminar on Regulatory Science(2017)
○Seminar of Medical Innovation(2017)
○Seminar on Regulatory Science(2016)
○Seminar of Medical Innovation(2016)
○Seminar of Medical Innovation(2016)
○Seminar of Medical Innovation(2016)
○Seminar on Regulatory Science(2016)

International Project

International Students

Lecture themes

Others (Social Activities)

To Page Top